Pulse Biosciences (NASDAQ:PLSE) Stock Price Down 7.4% – Time to Sell?

Pulse Biosciences, Inc. (NASDAQ:PLSE)’s stock price traded down 7.4% on Wednesday . The stock traded as low as $16.26 and last traded at $16.32. 75,692 shares changed hands during trading, a decline of 63% from the average session volume of 202,513 shares. The stock had previously closed at $17.63.

Wall Street Analyst Weigh In

Separately, StockNews.com raised Pulse Biosciences to a “sell” rating in a report on Friday, September 20th.

Pulse Biosciences Stock Performance

The stock has a market capitalization of $1.08 billion, a price-to-earnings ratio of -21.75 and a beta of 1.74. The company has a fifty day simple moving average of $17.90 and a two-hundred day simple moving average of $13.89.

Hedge Funds Weigh In On Pulse Biosciences

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. increased its stake in shares of Pulse Biosciences by 28.8% in the 1st quarter. Vanguard Group Inc. now owns 847,212 shares of the company’s stock valued at $7,379,000 after purchasing an additional 189,227 shares during the last quarter. Cetera Advisors LLC bought a new position in shares of Pulse Biosciences in the 1st quarter valued at $109,000. BNP Paribas Financial Markets increased its stake in shares of Pulse Biosciences by 63.6% in the 1st quarter. BNP Paribas Financial Markets now owns 7,597 shares of the company’s stock valued at $66,000 after purchasing an additional 2,952 shares during the last quarter. PNC Financial Services Group Inc. bought a new position in shares of Pulse Biosciences in the 4th quarter valued at $242,000. Finally, Price T Rowe Associates Inc. MD bought a new position in shares of Pulse Biosciences in the 1st quarter valued at $88,000. 76.95% of the stock is owned by institutional investors and hedge funds.

About Pulse Biosciences

Pulse Biosciences, Inc operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology.